Pentoxifylline treatment improves neurological and neurochemical deficits in rats subjected to transient brain ischemia

被引:18
作者
Bruno, Renata de Barros [1 ]
Marques, Tiago Fontenele [1 ]
Teixeira Batista, Tiago Melo [1 ]
Silveira Lima, Julio Cesar Sa [1 ]
de Arruda, Karla Gleice [1 ]
Souza Fiuza Lima, Priscili Fortaleza [1 ]
Santos, Nilton da Silva [1 ]
Cunha, Geanne M. A.
Nobre Vitor, Helio Vitorino [2 ]
de Barros Viana, Glauce Socorro [1 ,2 ]
机构
[1] FMJ, Dept Biophysiol & Pharmacol, BR-63040000 Juazeiro Do Norte, Ceara, Brazil
[2] Fed Univ Ceara UFC, Dept Physiol & Pharmacol, BR-60430270 Fortaleza, Ceara, Brazil
关键词
Pentoxifylline; Brain ischemia; Cognitive deficit; Neuroprotection; Striatal monoamine; FOCAL CEREBRAL-ISCHEMIA; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; CARDIAC DYSFUNCTION; ARTERY OCCLUSION; INFARCT VOLUME; DOPAMINE; MEMORY; INJURY; MOTOR;
D O I
10.1016/j.brainres.2008.12.064
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The possible neuroprotector effects of pentoxifylline (P), a methylxanthine derivative and phosphodiesterase inhibitor, were studied on male Wistar rats subjected to a model of transient brain ischemia. One group was treated, 1 h before ischemia (ISC) and 1 h after, with pentoxifylline (P), 50 and 100 mg/kg, i.p. (ISC+P). The other groups were ischemic, ISC; sham operated, SO; P100; SO+P100; and normal controls, N. One week after ischemia, the animals were submitted to the open field, passive avoidance, and water maze tests for evaluating locomotor activity and cognitive deficits, as well as for scintillographic (SPECT) measurements. After these procedures, they were sacrificed and their brain dissected under ice, for histological studies as well as striatal dopamine (DA) and DOPAC measurements by HPLC. In the open field test, ischemia increased locomotor activity, as compared to N, SO, P100 and SO+P100. This parameter was not significantly reversed after P treatment (ISC+P50 or ISC+P100). Grooming behavior was also increased in the ISC group, as compared to all other ones, although only statistically different as compared to the P100 group. The P treatment (ISC+P50 and ISC+P100) brought these values close to normality. In the passive avoidance test, ischemia significantly impaired the short term memory, as compared to the N group, as well as scopolamine (SCP) used as a positive control. In the long term memory, similar effects were observed in the ISC and SCP groups that significantly impaired memory consolidation. P treatment completely reversed the effects observed after ischemia (ISC+P50 and ISC+P100) on the short as well as on the long term memory, and values were similar to those of the P100 group (which increased both parameters, as related to the N group). In the water maze, the ISC group was not different from the N, SO and SO+P100 groups. However, ISC+P50, ISC+P100 and P100 significantly improved the spatial memory, as related to all other groups. SPECT data showed that ischemia produced a lower but significant decrease in brain optical densities, and P brought values close to those seen in the N group. Furthermore, P treatment of the ischemic group (ISC+P50) increased the number of viable hippocampal CA3 neurons, as compared to the ISC group. While ischemia significantly decreased DA levels, the P treatment of ischemic animals brought those values close to normality. In conclusion, P counteracted neurological and neurochemical changes seen after brain ischemia, in rats. The TNF-alpha inhibition and anti-inflammatory actions of P could be responsible, at least in part, for the neuroprotection afforded by the drug. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 58 条
[1]   Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle [J].
Araki, T ;
Tanji, H ;
Kato, H ;
Mizugaki, M ;
Itoyama, Y .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 8 (04) :261-267
[2]   Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring [J].
Bakos, J ;
Duncko, R ;
Makatsori, A ;
Pirnik, Z ;
Kiss, A ;
Jezova, D .
STRESS: CURRENT NEUROENDOCRINE AND GENETIC APPROACHES, 2004, 1018 :281-287
[3]   Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats [J].
Banfi, C ;
Sironi, L ;
De Simoni, G ;
Gelosa, P ;
Barcella, S ;
Perego, C ;
Gianazza, E ;
Guerrini, U ;
Tremoli, E ;
Mussoni, L .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 310 (03) :890-895
[4]   Tumor necrosis factor-alpha - A mediator of focal ischemic brain injury [J].
Barone, FC ;
Arvin, B ;
White, RF ;
Miller, A ;
Webb, CL ;
Willette, RN ;
Lysko, PG ;
Feuerstein, GZ .
STROKE, 1997, 28 (06) :1233-1244
[5]   TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice [J].
Bermpohl, Daniela ;
You, Zerong ;
Lo, Eng H. ;
Kim, Hyung-Hwan ;
Whalen, Michael J. .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (11) :1806-1818
[6]   STRIATAL DOPAMINE-MEDIATED MOTOR BEHAVIOR IS ALTERED FOLLOWING OCCLUSION OF THE MIDDLE CEREBRAL-ARTERY [J].
BORLONGAN, CV ;
MARTINEZ, R ;
SHYTLE, RD ;
FREEMAN, TB ;
CAHILL, DW ;
SANBERG, PR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 52 (01) :225-229
[7]   Loss of NF-κB activity during cerebral ischemia and TNF cytotoxicity [J].
Botchkina, GI ;
Geimonen, E ;
Bilof, ML ;
Villarreal, O ;
Tracey, KJ .
MOLECULAR MEDICINE, 1999, 5 (06) :372-381
[8]   PENTOXIFYLLINE INCREASES CEREBRAL BLOOD-FLOW IN PATIENTS WITH CEREBROVASCULAR-DISEASE [J].
BOWTON, DL ;
STUMP, DA ;
PROUGH, DS ;
TOOLE, JF ;
LEFKOWITZ, DS ;
COKER, L .
STROKE, 1989, 20 (12) :1662-1666
[9]   Potential of anticytokine therapies in central nervous system ischaemia [J].
Clark, WM ;
Lutsep, HL .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (02) :227-237
[10]   Pentoxifylline improves learning and memory in glutamate-lesioned rats [J].
Cunha, GMA ;
Bezerra, PJP ;
Saldanha, MDD ;
Cavalcante, MC ;
De Brun, VMS ;
Viana, GSB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2000, 66 (04) :687-694